Effectiveness of oral etoposide in recurrent or refractory epithelial ovarian cancer, primary peritoneal cancer and fallopian tube cancer-Reference-Cited by-同舟云学术

Effectiveness of oral etoposide in recurrent or refractory epithelial ovarian cancer, primary peritoneal cancer and fallopian tube cancer

Published:2022-04-26 Issue:6 Volume:42 Page:2331-2335
ISSN:0144-3615
Container-title:Journal of Obstetrics and Gynaecology
language:en
Short-container-title:Journal of Obstetrics and Gynaecology

Author:

Kongsawatvorakul Chompunoot¹,Charakorn Chuenkamon¹,Chittithaworn Suwicha¹,Lertkhachonsuk Arb-Aroon¹

Affiliation:

1. Department of Obstetrics & Gynaecology, Division of Gynaecologic Oncology, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand

Publisher

Informa UK Limited

Subject

Obstetrics and Gynecology

Link

https://www.tandfonline.com/doi/pdf/10.1080/01443615.2022.2049724

Reference24 articles.

1. Oral Etoposide (VP16) in Platinum-Resistant Epithelial Ovarian Cancer (EOC)

2. Phase I/II study of oral etoposide plus GM-CSF as second-line chemotherapy in platinum-pretreated patients with advanced ovarian cancer

3. Effectiveness of low-dose oral etoposide treatment in patients with recurrent and platinum-resistant epithelial ovarian cancer

4. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

5. [CTCAE] Common Terminology Criteria for Adverse Events (CTCAE) Version 4.0. 2010 [online]. Available from: http://purl.stanford.edu/nw036fx4646

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Potential Role of Phytochemicals of Juniperus procera in the Treatment of Ovarian Cancer and the Inhibition of Human Topoisomerase II Alpha Activity;Bioinformatics and Biology Insights;2024-01

2. Elevated Levels of Lamin A Promote HR and NHEJ-Mediated Repair Mechanisms in High-Grade Ovarian Serous Carcinoma Cell Line;Cells;2023-02-27